Ami Organics Limited IPO (Ami Organics IPO) Detail

Incorporated in 2004, Ami Organics Limited is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

The company has developed over 450 pharma intermediates across 17 key therapeutic areas i.e. anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. It supplies its products to more than 150 customers (including international customers) directly in India and in 25 countries overseas i.e. Europe, USA, China, Israel, Japan, Latin America, etc. Laurus Labs, Cadila Healthcare, Cipla Ltd are some of the domestic customers whereas Organike s.r.l.a. Socio Unico, Fermion Oly, Medichem S.A. and Midas Pharma GmbH are some of the international customers.

The company has three manufacturing facilities in Gujarat situated at Sachin, Ankleshwar & Jhagadia, with an aggregate installed capacity of 6,060 MTPA.

Competitive strengths:

  • One of the leading manufacturers of certain Pharma Intermediates i.e. Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban.
  • Strong and diversified product portfolio with 450+ Pharma Intermediates across 17 therapeutic areas.
  • Extensive geographical presence and diversified customer base.
  • Strong R&D, sales and marketing capabilities
  • Consistent financial performance track record.

Company Promoters:

Nareshkumar Ramjibhai Patel, Chetankumar Chhaganlal Vaghasia, Shital Nareshbhai Patel and Parul Chetankumar Vaghasia are the company promoters

Company Financials:

Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (₹ in Millions)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 4,132.68 2,318.92 2,131.52
Total Revenue 3,419.88 2,424.86 2,388.96
Profit After Tax 539.99 274.7 232.95

Objects of the Issue:

  • Repayment/prepayment of certain financial facilities availed by our Company.
  • Funding working capital requirements of our Company.
  • General corporate purposes.

Ami Organics IPO Details

IPO Opening Date Sep 1, 2021
IPO Closing Date Sep 3, 2021
Issue Type Book Built Issue IPO
Face Value ₹10 per equity share
IPO Price ₹603 to ₹610 per equity share
Market Lot 24 Shares
Min Order Quantity 24 Shares
Listing At BSE, NSE
Issue Size [.] Eq Shares of ₹10
(aggregating up to ₹569.64 Cr)
Fresh Issue [.] Eq Shares of ₹10
(aggregating up to ₹200.00 Cr)
Offer for Sale 6,059,600 Eq Shares of ₹10
(aggregating up to ₹369.64 Cr)

Ami Organics IPO Tentative Timetable

The Ami Organics IPO open date is Sep 1, 2021, and the close date is Sep 3, 2021. The issue may list on Sep 14, 2021.

IPO Open Date Sep 1, 2021
IPO Close Date Sep 3, 2021
Basis of Allotment Date Sep 8, 2021
Initiation of Refunds Sep 9, 2021
Credit of Shares to Demat Account Sep 13, 2021
IPO Listing Date Sep 14, 2021

Ami Organics IPO Lot Size

The Ami Organics IPO market lot size is 24 shares. A retail-individual investor can apply for up to 13 lots (312 shares or ₹190,320).

Application Lots Shares Amount (Cut-off)
Minimum 1 24 ₹14,640
Maximum 13 312 ₹190,320

Ami Organics IPO Promoter Holding

Pre Issue Share Holding 47.23%
Post Issue Share Holding 41.05%

Ami Organics IPO Subscription Status (Bidding Detail)

The Ami Organics IPO is subscribed 0.35x times on Sep 1, 2021 10:48. The public issue subscribed 0.69x in the retail category, 0.00x in the QIB category, and 0.00x in the NII category.

Category IPO Subscription
QIB  0.00x
NII  0.00x
RII  0.69x
Total  0.35x

Company Contact Information

Ami Organics Limited
Plot No. 440/4, 5 & 6, Road No. 82/A
GIDC Sachin, Surat – 394 230

Phone: +91 261 239 7193
Email: [email protected]

Ami Organics IPO Registrar

Leave your thoughts